Agilon Health, a leading medical and nursing services company, has revised its financial outlook for the year. The company now anticipates adjusted losses before interest, taxes, depreciation, and amortization, while also reducing its full-year revenue guidance.
Adjusted Ebitda and Revenue Projections
Previously, Agilon Health had projected an adjusted Ebitda in the range of $6 million to $18 million. However, the company now expects a negative adjusted Ebitda between $55 million and $69 million. This adjustment reflects the evolving financial landscape.
Furthermore, Agilon Health has adjusted its revenue guidance from $4.31 billion to $4.30 billion, which is slightly lower than its previous projection of up to $4.32 billion.
Factors Influencing the Adjustments
Agilon Health attributes these adjustments to higher-than-expected medical expenses. The company now forecasts a medical margin of $340 million to $360 million, roughly $110 million lower than its previous guidance. This demonstrates a proactive response to the challenges faced in today’s healthcare environment.
Future Outlook for Agilon Health
Looking ahead to 2024, Agilon Health anticipates a substantial increase in revenue, projecting a range of $6.35 billion to $6.42 billion. This forecast showcases the company’s commitment to continued growth and success.
Management at Agilon Health acknowledges the need for ongoing measures to improve visibility, balance risk-sharing, and enhance predictability of results. Additionally, they anticipate higher costs persisting into 2024.